$DX
DYNEX CAPITAL INC

2021 Q2 Form 10-Q Financial Statement

#000082667521000073 Filed on August 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $13.39M $19.90M
YoY Change -32.7% -54.46%
Cost Of Revenue $1.275M $4.900M
YoY Change -73.98% -84.09%
Gross Profit $12.12M $15.00M
YoY Change -19.21% 16.28%
Gross Profit Margin 90.48% 75.38%
Selling, General & Admin $5.706M $4.800M
YoY Change 18.88% 11.63%
% of Gross Profit 47.09% 32.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $506.0K $500.0K
YoY Change 1.2% 0.0%
% of Gross Profit 4.18% 3.33%
Operating Expenses $6.029M $5.000M
YoY Change 20.58% 25.0%
Operating Profit $6.089M $10.00M
YoY Change -39.11% 12.36%
Interest Expense $1.275M $4.850M
YoY Change -73.71% -84.26%
% of Operating Profit 20.94% 48.5%
Other Income/Expense, Net
YoY Change
Pretax Income -$43.76M $194.8M
YoY Change -122.46% -263.7%
Income Tax
% Of Pretax Income
Net Earnings -$43.76M $194.8M
YoY Change -122.46% -263.75%
Net Earnings / Revenue -326.73% 979.09%
Basic Earnings Per Share -$1.43 $8.31
Diluted Earnings Per Share -$1.43 $8.31
COMMON SHARES
Basic Shares Outstanding 31.97M shares 23.06M shares
Diluted Shares Outstanding 31.97M shares 23.06M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $349.4M $147.2M
YoY Change 137.35% 194.4%
Cash & Equivalents $349.4M $147.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $15.11M $172.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $364.5M $319.9M
YoY Change 13.94% 318.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.001B $3.504B
YoY Change -14.37% -38.78%
Other Assets $85.34M $59.20M
YoY Change 44.16% -3.58%
Total Long-Term Assets $3.110B $3.578B
YoY Change -13.08% -38.23%
TOTAL ASSETS
Total Short-Term Assets $364.5M $319.9M
Total Long-Term Assets $3.110B $3.578B
Total Assets $3.474B $3.898B
YoY Change -10.86% -33.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $405.0K $900.0K
YoY Change -55.0% -94.34%
Deferred Revenue
YoY Change
Short-Term Debt $2.321B $3.315B
YoY Change -29.98% -31.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.678B $3.322B
YoY Change -19.36% -36.91%
LONG-TERM LIABILITIES
Long-Term Debt $9.326M $1.300M
YoY Change 617.38% -58.06%
Other Long-Term Liabilities $30.95M $7.200M
YoY Change 329.89% 166.67%
Total Long-Term Liabilities $40.28M $8.500M
YoY Change 373.86% 46.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.678B $3.322B
Total Long-Term Liabilities $40.28M $8.500M
Total Liabilities $2.719B $3.330B
YoY Change -18.36% -36.81%
SHAREHOLDERS EQUITY
Retained Earnings -$447.6M -$547.7M
YoY Change -18.27% -9.05%
Common Stock $1.066B $858.5M
YoY Change 24.14% -2.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $755.6M $567.5M
YoY Change
Total Liabilities & Shareholders Equity $3.474B $3.898B
YoY Change -10.86% -33.59%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$43.76M $194.8M
YoY Change -122.46% -263.75%
Depreciation, Depletion And Amortization $506.0K $500.0K
YoY Change 1.2% 0.0%
Cash From Operating Activities $37.65M $39.50M
YoY Change -4.67% -11.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$323.7M $1.163B
YoY Change -127.83% -281.71%
Cash From Investing Activities -$323.7M $1.163B
YoY Change -127.83% -281.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 561.2M -1.107B
YoY Change -150.7% -296.21%
NET CHANGE
Cash From Operating Activities 37.65M 39.50M
Cash From Investing Activities -323.7M 1.163B
Cash From Financing Activities 561.2M -1.107B
Net Change In Cash 275.2M 95.80M
YoY Change 187.24% -405.1%
FREE CASH FLOW
Cash From Operating Activities $37.65M $39.50M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
dei Entity Central Index Key
EntityCentralIndexKey
0000826675
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-9819
dei Entity Registrant Name
EntityRegistrantName
DYNEX CAPITAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1549373
dei Entity Address Address Line1
EntityAddressAddressLine1
4991 Lake Brook Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Glen Allen,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23060-9245
dei City Area Code
CityAreaCode
(804)
dei Local Phone Number
LocalPhoneNumber
217-5800
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34591535 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349381000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295602000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
85342000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
14758000 USD
CY2021Q2 us-gaap Pledged Financial Instruments Not Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment
PledgedFinancialInstrumentsNotSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment
2473257000 USD
CY2020Q4 us-gaap Pledged Financial Instruments Not Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment
PledgedFinancialInstrumentsNotSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment
2467859000 USD
CY2021Q2 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
2995502000 USD
CY2020Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
2596255000 USD
CY2021Q2 us-gaap Financial Instruments Owned Other At Fair Value
FinancialInstrumentsOwnedOtherAtFairValue
5146000 USD
CY2020Q4 us-gaap Financial Instruments Owned Other At Fair Value
FinancialInstrumentsOwnedOtherAtFairValue
6264000 USD
CY2021Q2 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
1057000 USD
CY2020Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
150432000 USD
CY2021Q2 us-gaap Derivative Assets
DerivativeAssets
16854000 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
11342000 USD
CY2021Q2 us-gaap Interest Receivable
InterestReceivable
14056000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
14388000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6957000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6394000 USD
CY2021Q2 us-gaap Assets
Assets
3474295000 USD
CY2020Q4 us-gaap Assets
Assets
3095435000 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2321043000 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2437163000 USD
CY2021Q2 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
350854000 USD
CY2020Q4 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
5000 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
27325000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1634000 USD
CY2021Q2 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
9326000 USD
CY2020Q4 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
7681000 USD
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
405000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1410000 USD
CY2021Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6086000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5814000 USD
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
3627000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
8275000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2718666000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2461982000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4460000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4460000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7248330 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7248330 shares
CY2021Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
111500000 USD
CY2020Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
181208000 USD
CY2021Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
107843000 USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
174564000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34344566 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34344566 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23697970 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23697970 shares
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
343000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
237000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1065670000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
869495000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29375000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
80261000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447602000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491104000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
755629000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
633453000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3474295000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
59676000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
1275000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
4850000 USD
us-gaap Interest Expense
InterestExpense
2908000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3095435000 USD
CY2021Q2 us-gaap Interest Income Operating
InterestIncomeOperating
13393000 USD
CY2020Q2 us-gaap Interest Income Operating
InterestIncomeOperating
19853000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
27285000 USD
us-gaap Interest Expense
InterestExpense
26952000 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12118000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15003000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
24377000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
32724000 USD
CY2021Q2 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
2008000 USD
CY2020Q2 us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
193099000 USD
us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
6705000 USD
us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
277882000 USD
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
1084000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
332000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
104000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-40000 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-52940000 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-8563000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54861000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-204130000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-323000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-222000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-703000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-645000 USD
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3233000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2736000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
6329000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4898000 USD
CY2021Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2473000 USD
CY2020Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2075000 USD
CY2021Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1923000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4845000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4534000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-43759000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
194838000 USD
us-gaap Net Income Loss
NetIncomeLoss
74170000 USD
us-gaap Net Income Loss
NetIncomeLoss
96359000 USD
CY2020Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3253000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4482000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7094000 USD
CY2021Q2 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
0 USD
CY2020Q2 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
0 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
2987000 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
3914000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45682000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
191585000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
66701000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
85351000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16278000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28052000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-44181000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
185807000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
2008000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
193099000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
6705000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
277882000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14270000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-165047000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50886000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-92075000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31412000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26538000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15815000 USD
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.31
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6724000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31973587 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23056812 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29395463 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23009948 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31973587 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31973587 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23056812 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29560522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29560522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23009948 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.71
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2559000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.71
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.88
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
582988000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107988000 USD
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
100000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
307000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
206000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
235000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-98479000 USD
CY2020Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3841000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10330000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
72972000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
8000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
550607000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
423000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
166000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
194838000 USD
CY2020Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3253000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9925000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-165047000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567469000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
633453000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
128150000 USD
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
69708000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
451000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
428000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
270000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
117929000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10586000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-65156000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
731276000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
68302000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
444000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
100000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
425000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
43000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-43759000 USD
CY2021Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1923000 USD
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12613000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14270000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
755629000 USD
us-gaap Net Income Loss
NetIncomeLoss
74170000 USD
us-gaap Net Income Loss
NetIncomeLoss
96359000 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
6705000 USD
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
277882000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83469000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
104000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-40000 USD
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
54861000 USD
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-204130000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
60123000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
63789000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1106000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
959000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
995000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
731000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-332000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-9589000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1005000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-14678000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
6197000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-432000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67854000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1052490000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2818863000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
223706000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
249766000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
474657000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4226321000 USD
us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
1171000 USD
us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
1519000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-425889000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
210712000 USD
us-gaap Increase Decrease Cash Collateral From Counterparties
IncreaseDecreaseCashCollateralFromCounterparties
1645000 USD
us-gaap Increase Decrease Cash Collateral From Counterparties
IncreaseDecreaseCashCollateralFromCounterparties
394000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
74578000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1448425000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
7955673000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
23686649000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
8071793000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
25124006000 USD
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-118000 USD
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-1467000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
107988000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
196452000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
69708000 USD
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
100000000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
313000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
372000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
853000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
235000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
27409000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
27894000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18069000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1459337000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
124363000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
72557000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
310360000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134230000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
434723000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206787000 USD
us-gaap Interest Paid Net
InterestPaidNet
3906000 USD
us-gaap Interest Paid Net
InterestPaidNet
41613000 USD
us-gaap Nature Of Operations
NatureOfOperations
OrganizationDynex Capital, Inc. (“Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company is an internally managed mortgage real estate investment trust, or mortgage REIT, which primarily earns income from investing on a leveraged basis in debt securities, the majority of which are specified pools of Agency mortgage-backed securities (“MBS”) consisting of commercial MBS (“CMBS”), residential MBS (“RMBS”), and CMBS interest-only (“IO”) securities and non-Agency MBS, which consist mainly of CMBS IO. Agency MBS have a guaranty of principal payment by a U.S. government-sponsored entity (“GSE”) such as Fannie Mae and Freddie Mac, which are in conservatorship and are currently supported by a senior preferred stock purchase agreement from the U.S. Treasury. Non-Agency MBS are issued by non-governmental enterprises and do not have a guaranty of principal payment. The Company also invests in other types of mortgage-related securities, such as to-be-announced securities (“TBAs” or “TBA securities”).
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts and fair value measurements of its investments. These items are discussed further below within this note to the consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the estimates and assumptions underlying the consolidated financial statements included herein are reasonable and supportable based on the information available as of June 30, 2021; however, the uncertainty over the impact that the COVID-19 pandemic may continue to have on the global economy and on the Company’s business makes any estimates and assumptions inherently less certain than they would be absent the current and potential impacts of COVID-19. The COVID-19 pandemic and resulting emergency measures have led (and may continue to lead) to significant disruptions in the global capital markets and supply chains as well as the economy of the U.S. and other countries impacted by COVID-19. In particular, as part of the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act passed by the U.S. Congress, which includes assistance to homeowners and renters, both Fannie Mae and Freddie Mac implemented mortgage forbearance policies that allowed borrowers to delay their mortgage payments for up to 18 months and placed a moratorium on foreclosures on single-family homes until June 30, 2021. In addition, to provide assistance to families still struggling to pay their rent and to help multifamily property owners maintain their properties, Fannie Mae and Freddie Mac are extending the multifamily COVID-19 forbearance protection to qualifying borrowers and extending the moratorium on tenant evictions through the end of September 2021. The impact of high levels of forbearance on the loans underlying the Company’s MBS could range from immaterial to significant depending upon not only actual losses incurred on underlying loans but also future public policy choices and actions by the GSEs, their regulator the Federal Housing Finance Agency (“FHFA”), the U.S. Federal Reserve (“Federal Reserve”), and federal and state governments. The nature and timing of any </span></div>such future public policy choices and actions are unpredictable, including the potential impact on MBS prices and prepayment speeds. Though these supportive actions have helped cushion the economic damage from the disruption of the pandemic to date, the Company can give no assurance as to how, in the long term, these and other actions by the U.S. government and GSEs will affect the efficiency, liquidity and stability of the financial and mortgage markets.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Certain items on the Company’s consolidated balance sheet as of December 31, 2020 have been reclassified to conform to the current period’s presentation. In the Company’s 2020 Form 10-K, restricted cash on the consolidated balance sheet as of December 31, 2020 consisted of the cash collateral posted by the Company to its counterparties to cover initial and variation margin related to its financing and derivative instruments, net of any cash collateral received by the Company from its counterparties. Restricted cash has been renamed “cash collateral posted to counterparties” within total assets, and cash collateral of $7,681 posted by counterparties as of December 31, 2020 has been reclassified to “cash collateral posted by counterparties” within total liabilities.</span></div>
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
7681000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349381000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
85342000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
434723000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2300000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31973587 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23056812 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29395463 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23009948 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31973587 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31973587 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23056812 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29560522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29560522 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23009948 shares
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45682000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
191585000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
66701000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
85351000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.71
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.71
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165059 shares
CY2021Q2 dx Parvalueofavailableforsaledebtsecurity
Parvalueofavailableforsaledebtsecurity
1544607000 USD
CY2021Q2 dx Investments Unamortized Premium Discount
InvestmentsUnamortizedPremiumDiscount
373335000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1917942000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
38629000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9255000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1947316000 USD
CY2021Q2 dx Par Value Of Debt Security Fair Value Option Elected
ParValueOfDebtSecurityFairValueOptionElected
1013404000 USD
CY2021Q2 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
1048149000 USD
us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
467000 USD
us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
430000 USD
CY2021Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
1048186000 USD
CY2021Q2 us-gaap Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
2995502000 USD
CY2020Q4 dx Parvalueofavailableforsaledebtsecurity
Parvalueofavailableforsaledebtsecurity
2076346000 USD
CY2020Q4 dx Investments Unamortized Premium Discount
InvestmentsUnamortizedPremiumDiscount
439649000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2515995000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
81293000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1033000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2596255000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2596255000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
250453000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
2008000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2391334000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
193099000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
325282000 USD
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
6705000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
4382368000 USD
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
277882000 USD
CY2020Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
2
CY2021Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2021Q2 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
2321043000 USD
CY2021Q2 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0021
CY2021Q2 us-gaap Assets Sold Under Agreements To Repurchase Carrying Amounts
AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts
2473257000 USD
CY2020Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
2437163000 USD
CY2020Q4 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0034
CY2020Q4 us-gaap Assets Sold Under Agreements To Repurchase Carrying Amounts
AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts
2609075000 USD
CY2020Q4 dx Amortized Cost Of Securities Sold But Unsettled
AmortizedCostOfSecuritiesSoldButUnsettled
141215000 USD
CY2020Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
150432000 USD
CY2020Q4 dx Repurchase Agreement Amount Outstanding For Which Securities Sold But Not Settled As Of The Reporting Date Are Pledged As Collateral
RepurchaseAgreementAmountOutstandingForWhichSecuritiesSoldButNotSettledAsOfTheReportingDateArePledgedAsCollateral
140612000 USD
CY2021Q2 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
350854000 USD
CY2020Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
5000 USD
CY2021Q2 dx Number Of Counterparties Borrowings Outstanding
NumberOfCounterpartiesBorrowingsOutstanding
23 Agreements
CY2021Q2 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
2321043000 USD
CY2021Q2 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0021
CY2021Q2 dx Originaltermtomaturity
Originaltermtomaturity
106
CY2020Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
2437163000 USD
CY2020Q4 us-gaap Assets Sold Under Agreements To Repurchase Interest Rate
AssetsSoldUnderAgreementsToRepurchaseInterestRate
0.0034
CY2020Q4 dx Originaltermtomaturity
Originaltermtomaturity
44
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000000 USD
CY2021Q2 us-gaap Line Of Credit
LineOfCredit
105363000 USD
CY2021Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0097
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2321043000 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2321043000 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
2321043000 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 USD
CY2021Q2 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
2437163000 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
2437163000 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
2437163000 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-52940000 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-8563000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54861000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-204130000 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
16854000 USD
CY2020Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
11342000 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
27325000 USD
CY2020Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
1634000 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
16854000 USD
CY2021Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2021Q2 us-gaap Derivative Assets
DerivativeAssets
16854000 USD
CY2021Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0 USD
CY2021Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
8781000 USD
CY2021Q2 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
8073000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
11342000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
11342000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
107000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
7681000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
3554000 USD
CY2021Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
27325000 USD
CY2021Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
27325000 USD
CY2021Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0 USD
CY2021Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
27325000 USD
CY2021Q2 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1634000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1634000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
107000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
1527000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
544000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
995000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
424000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
731000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
5695000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D

Files In Submission

Name View Source Status
0000826675-21-000073-index-headers.html Edgar Link pending
0000826675-21-000073-index.html Edgar Link pending
0000826675-21-000073.txt Edgar Link pending
0000826675-21-000073-xbrl.zip Edgar Link pending
a2q21ex-311ceocertification.htm Edgar Link pending
a2q21ex-312cfocertification.htm Edgar Link pending
a2q21ex-321soxcertification.htm Edgar Link pending
dx-20210630.htm Edgar Link pending
dx-20210630.xsd Edgar Link pending
dx-20210630_cal.xml Edgar Link unprocessable
dx-20210630_def.xml Edgar Link unprocessable
dx-20210630_g1.jpg Edgar Link pending
dx-20210630_g2.jpg Edgar Link pending
dx-20210630_g3.jpg Edgar Link pending
dx-20210630_htm.xml Edgar Link completed
dx-20210630_lab.xml Edgar Link unprocessable
dx-20210630_pre.xml Edgar Link unprocessable
ex10411.htm Edgar Link pending
exh1040annualcashincentive.htm Edgar Link pending
exh10412rsuagreement2020pl.htm Edgar Link pending
exh10413psuagreement2020pl.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending